Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy
Pablo Barreiro(Hospital Clínico San Carlos), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Karin Neukam(Hospital Universitario de Valme), Antonio Rivero(University of Southern California), Ángela Camacho(Hospital Universitario Reina Sofía), Susanna Naggie(Duke University), Norma Rallón(Hospital Universitario Rey Juan Carlos), José M. Benito(Hospital Universitario Rey Juan Carlos), Luz Martín‐Carbonero, John G. McHutchison(Gilead Sciences (United States)), Juan A. Pineda(Hospital Universitario de Valme), Eugenia Vispo, Antonio Carúz(Universidad de Jaén), J. Medraño
Cited by 58
Related Papers
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k